Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)
European Journal of Cancer2011Vol. 47(10), pp. 1476–1483
Citations Over TimeTop 1% of 2011 papers
Poulam M. Patel, Stefan Suciu, Laurent Mortier, Wim H.J. Kruit, Caroline Robert, Dirk Schadendorf, Uwe Trefzer, Cornelis J.A. Punt, Reinhard Dummer, Neville Davidson, Juergen C. Becker, Robert M. Conry, John A. Thompson, Wen-Jen Hwu, Kristel Engelen, Sanjiv S. Agarwala, Ulrich Keilholz, Alexander M.M. Eggermont, Alan Spatz
Related Papers
- → Temozolomide: a novel oral alkylating agent(2001)111 cited
- → Temozolomide for the Treatment of Metastatic Melanoma: A Systematic Review(2007)141 cited
- → Phase II evaluation of temozolomide in metastatic choroidal melanoma(2003)74 cited
- → Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma(2008)2 cited
- → Alternative temozolomide dosing regimens and novel combinations for the treatment of advanced metastatic melanoma(2011)